Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.
- Resource Type
- journal article
- Source
- BMC Pediatrics; 7/14/2017, Vol. 17, p1-10, 10p, 1 Diagram, 2 Charts
- Subject
RETROLENTAL fibroplasia PROPRANOLOL NEOVASCULARIZATION PEDIATRICS PEDIATRIC ophthalmology THERAPEUTICS ADRENERGIC beta blockers OPHTHALMIC drugs CLINICAL trials COMPARATIVE studies PREMATURE infants LONGITUDINAL method RESEARCH methodology MEDICAL cooperation RESEARCH protocols RESEARCH CUTANEOUS therapeutics EVALUATION research TREATMENT effectiveness - Language
- ISSN
- 14712431